Article citationsMore>>

Clark, J.W., Snell, L., Shiu, R.P., Orr, F.W., Maitre, N., Vary, C.P., Cole, D.J. and Watson, P.H. (1999) The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis. British Journal of Cancer, 81, 1002-1008. http://dx.doi.org/10.1038/sj.bjc.6690799

has been cited by the following article:

• TITLE: The prolactin-inducible-protein (PIP): A regulatory molecule in adaptive and innate immunity

  AUTHORS: Vivake Umadat, Olivia Ihedioha, Robert Shiu, Jude Uzonna, Yvonne Myal

  KEYWORDS: Prolactin-Inducible-Protein (PIP); Immunoregulation; Innate Immunity; Adaptive Immunity

  JOURNAL NAME: Open Journal of Immunology, Vol.3 No.4, December 12, 2013

  ABSTRACT: The Prolactin-inducible-protein (PIP)/Gross Cystic Disease Fluid Protein-15 (GCDFP-15) gene is highly expressed in salivary, lacrimal and sweat glands and the protein abundantly found in the secretions that originate from these glands; saliva, tears and sweat. PIP is thus considered to be strategically located at sites viewed as the first port of entry for invading organisms. PIP is also found over-expressed under abnormal and pathological conditions of the breast and prostate. The function of PIP has yet to be defined but it has been implicated to play a role in immunity, with respect to bacterial and viral infection, cancer and fertility. Despite such predictive functions, there is still no clear demonstration of an immunoregulatory role for PIP. In this review we will focus on accumulating evidence that suggests a role for PIP in both innate and adaptive immunity. Moreover, we will discuss recent evidence that defines a modulatory role for PIP with regards to a CD4+ T cell immune response, identifying for the first time, a critical role for PIP in effective cell-mediated immunity against an intracellular pathogen.